• Western blot analysis of bewo, using CXCR6 Rabbit polyclonal antibody (STJ11105170) at 1:2000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) (STJS000856) at 1:10000 dilution. Lysates/proteins: 25 Mu g per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 10s.

Anti-CXCR6 antibody (STJ11105170)

SKU:
STJ11105170

Current Stock:
Host: Rabbit
Applications: WB
Reactivity: Human
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-C-X-C Chemokine Receptor Type 6 is suitable for use in Western Blot research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: PBS with 0.02% Sodium Azide, 50% Glycerol, pH7.3.
Purification: Affinity purification
Dilution Range: WB 1:1000-1:5000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: CXCR6
Gene ID: 10663
Uniprot ID: CXCR6_HUMAN
Immunogen: Recombinant protein of human CXCR6.
Tissue Specificity Expressed in lymphoid tissues and activated T cells.
Function Receptor for the C-X-C chemokine CXCL16. Used as a coreceptor by SIVs and by strains of HIV-2 and m-tropic HIV-1.
Protein Name C-X-C Chemokine Receptor Type 6
Cxc-R6
Cxcr-6
Cdw186
G-Protein Coupled Receptor Strl33
G-Protein Coupled Receptor Bonzo
Cd Antigen Cd186
Database Links Reactome: R-HSA-380108
Reactome: R-HSA-418594
Cellular Localisation Cell Membrane
Multi-Pass Membrane Protein
Alternative Antibody Names Anti-C-X-C Chemokine Receptor Type 6 antibody
Anti-Cxc-R6 antibody
Anti-Cxcr-6 antibody
Anti-Cdw186 antibody
Anti-G-Protein Coupled Receptor Strl33 antibody
Anti-G-Protein Coupled Receptor Bonzo antibody
Anti-Cd Antigen Cd186 antibody
Anti-CXCR6 antibody
Anti-BONZO antibody
Anti-STRL33 antibody
Anti-TYMSTR antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance